Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Unboosted Atazanavir as Initial ART Therapy in China

NCT01459575 is registered in ClinicalTrials.gov with National Center for AIDS/STD Control and Prevention, China CDC as lead sponsor.

NCT NCT01459575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01459575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Unboosted Atazanavir as Initial ART Therapy in China
Lead sponsor
National Center for AIDS/STD Control and Prevention, China CDC
Phase
Observational
Overall status
Completed
Start date
July 31, 2005
Completion date
December 31, 2006
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiretroviral therapy